Long-term care pharmacies are struggling with an Affordable Care Act provision related to short-cycle dispensing of brand name oral solid drugs, according to a recent letter from the Long Term Care Pharmacy Alliance and the National Community Pharmacists Association. Providers raised concerns that a short-cycle dispensing requirement might fuel additional dispensing fees and labor costs that would offset any savings from reducing the amount of unused drugs. Policymakers must quickly come up with a better definition of “brand name drugs,” according to the letter the two groups recently sent to the Centers for Medicare & Medicaid Services.
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions
